Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats

Cardiovascular Drugs and Therapy

Volumn 14, Issue 5, 2000, Pages 533-542

  Minamino, Tetsuo ^a   Kitakaze, Masafumi ^a   Papst, Philip J ^b   Ueda, Yasunori ^a   Sakata, Yasuhiko ^a   Asanuma, Hiroshi ^a   Ogai, Akiko ^a   Kuzuya, Tsunehiko ^a   Terada, Naohiro ^b   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

ACE inhibitor; Hydralazine; L NAME; Protein synthesis; Rapamycin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; IMIDAPRIL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; RAPAMYCIN; S6 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART VENTRICLE HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CORONARY VESSELS; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; HYDRALAZINE; IMIDAZOLES; IMIDAZOLIDINES; IMMUNOSUPPRESSIVE AGENTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, INBRED WKY; RIBOSOMAL PROTEIN S6 KINASES; SIROLIMUS; VENTRICULAR REMODELING;

EID: 0033794721     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007897308187     Document Type: Article

References (50)

1. Control of coronary vascular tone by nitric oxide
2. Nitric oxide: Physiology, pathophysiology, and pharmacology
3. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells
4. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
5. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide
6. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase
7. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis
8. Rapamycin selectively inhibits angiotensin li-induced increase in protein synthesis in cardiac myocytes in vitro
9. Rapamycin inhibits α1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertophy-associated genes. Evidence for involvement of p70 S6 kinase
10. Alternations in vascular smooth muscle mass in the spontaneously hypertensive rat: Role of cellular hypertrophy, hyperploidy and hyperplasia
11. p70 S6 kinase: An enigma with variations
12. The 70 kDa S6 kinase: Regulation of a kinase with multiple roles in mitogenic signaling
13. Mitogenesis and protein synthesis: A role for ribosomal protein S6 phosphorylation?
14. Phosphatidylinositol 3'-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells
15. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells
16. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts
17. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kd S6 protein kinases
18. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase
19. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats
20. Pharamcological studies on TA-6366, a new inhibitor: II. Effects of long-term administration from the prehypertensive stage on blood pressure, relative heart weight and ACE activity of various tissues in spontaneously hypertensive rats (SHRs)
21. Sirolimus, a potent new immunosuppressive drug for organ transplantation
22. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat
23. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase
24. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins
25. Protein measurement with the Folin phenol reagent
26. Sequence and expression of chicken and mouse rsk: Homologs of Xenopus laevis ribosomal S6 kinase
27. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension
28. L-arginine inhibits balloon catheter-induced intimal hyperplasia
29. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
30. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia
31. The renin-angiotensin system and vascular hypertrophy
32. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II
33. Induction of platelet-derived growth factor A chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth cells
34. Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C
35. Transgenic Gq overexpression induces cardiac contractile failure in mice
36. Translational dynamics Interactions between the translational factors, tRNA and ribosomes during eukaryotic protein synthesis
37. Activation of pp70/85 S6 kinase in interleukin-2-responsive lymphoid cells is mediated by phophatidylinositol 3 kinase and inhibited by cyclic AMP
38. PDGF- and insulin-dependent ppS6k activation mediated by phosphatidylinositol-3-OH kinase
39. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: An alternative route to mitogen-induced gene expression
40. Immunophilins and the nervous system
41. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointimal proliferation
42. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs
43. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes
44. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors: A new dimension in antiischaemic therapy?
45. Reversal of left ventricular hypertrophy in hypertensive patients
46. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomized double-blind studies
47. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes
48. Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes
49. MAP2 kinase and 70K S6 kinase lie on distinct signaling pathways
50. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action